TATVA — Tatva Chintan Pharma Chem Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹34.08bn
- IN₹34.74bn
- IN₹3.83bn
- 78
- 4
- 100
- 68
Annual cashflow statement for Tatva Chintan Pharma Chem, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
C2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 607 | 1,041 | 448 | 436 | 75.8 |
| Depreciation | |||||
| Non-Cash Items | 0.86 | 17.8 | 112 | 30 | 16.5 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -478 | -937 | -377 | 259 | -122 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 197 | 204 | 278 | 980 | 247 |
| Capital Expenditures | -210 | -892 | -2,031 | -1,285 | -763 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 3.11 | -1,076 | 1,020 | 79.8 | 110 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -207 | -1,968 | -1,011 | -1,205 | -653 |
| Financing Cash Flow Items | -42.7 | 2,032 | -128 | 1,841 | -12.9 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -47.1 | 2,350 | 378 | 305 | 166 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -56.8 | 585 | -357 | 79.4 | -239 |